SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ENDRA Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business Update

ENDRA Life Sciences Inc. (NASDAQ:NDRA) (“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today reported financial results for the third quarter ended September 30, 2026, and provided a business update.Busin…

ASPINDRA

Related stories